LEE GARY K. (Chief Scientific Officer) sold 8.2% of their position (1.46K shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $22.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/25/2026ACC: 0001907345-26-000006
Officer· Chief Scientific Officer
Since Jan 2022
-1.46K
Net shares
Net seller
$22.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.46K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.46K
Price / share
$15.54
Trade value
$22.64K
% of position
8.2%
8/21/2026
17.68K→16.22K
Total
Net shares
−1.46K
Net value
-$22.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2026 | S · Sale | −1.46K | $15.54 | $22.64K | 8.2% | 17.68K | 16.22K |
| Total | −1.46K | -$22.64K | ||||||
Derivative Transactions0
No derivative transactions reported